More recently, in another of 45 AD patients, 18 MCI subjects, and 23 non-demented controls, elevated concentrations of YKL-40, a marker of glial inflammation, correlated significantly with increased albumin ratio and decreased Abeta42/40 ratio in AD patients (Muszynski et al., 2017). This evidence concerns the gene CHI3L1 and Alzheimer disease.